Navigation Links
NITTO DENKO Avecia Inc. Introduces Dedicated Pre-Clinical Oligonucleotide Service, OliGrow
Date:5/13/2013

Milford, Massachusetts (PRWEB) May 13, 2013

NITTO DENKO Avecia Inc., an industry leader in therapeutic nucleic acid manufacturing and development services, is proud to introduce a new pre-clinical oligonucleotide synthesis service, OliGrow. Combining phase appropriate quality and purity standards with a high level of customer service, the Avecia OliGrow team delivers pre-clinical oligonucleotides at µmol to mmol scales, with affordable pricing and fast turn around times.

OliGrow offers custom DNA and RNA with standard chemical modifications, along with advanced solutions for more specialized needs, including oligonucleotide conjugates and specialty amidites. Its experts operate within a dedicated facility at Avecia’s FDA- registered Cincinnati, OH plant, and use instrumentation, methods, and analytics designed for scalability and consistency throughout the development process.

As the only oligonucleotide CMO that can deliver both the first µmols of pre-clinical material and bring a program through to commercialization, Avecia OliGrow creates value for its customers by building compound knowledge from the very start, avoiding future surprises and costly technical transfers and process changes.

Dr. Marc Lemaitre, Avecia’s VP for New Businesses and Services, says the company is very proud to bring this small scale service under the same roof as the large scale, clinical productions. “Previous options to bridge the gap between pure research and clinical production in the oligo space were largely accomplished through collaborations and partnerships between multiple companies. But now are pleased to offer OliGrow as a unique, one- stop option for oligonucleotide developers.”

ABOUT NITTO DENKO Avecia Inc.

NITTO DENKO Avecia, Inc. is a drug development and manufacturing services company located in Milford, MA, and is a part of Nitto Denko Corporation, Japan’s leading diversified materials manufacturer. Avecia is a recognized leader process development, manufacture, and related services for DNA and RNA-based therapeutics. All services are offered, from preclinical testing to post-commercial launch of innovative oligonucleotide-based therapeutics. To see what Avecia can do for your business, visit http://www.avecia.com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10715509.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GeneTex Introduces New Mouse Monoclonal Antibody Against the Ten-Eleven Translocation 1 (TET1) Protein for DNA Methylation/Epigenetics Research
2. Montclair Breast Center introduces 3D Mammography.
3. Adult Acne Treatment, Probiotic Action Introduces their Antibiotic-Free Acne Treatment
4. ChanTest Introduces the CardioChannelGram™ and SaVety Assessment
5. Diagenode Introduces Innovative Bioruptor® Pico for Micro-Volume Chromatin and DNA Shearing
6. Texas Fertility Center Introduces Oncofertility Education Program for Physicians and Patients
7. Finesse Solutions Introduces SmartParts for Intelligent Universal Controllers
8. Cearna Introduces Product Designed to Reduce Patient’s Recovery Time From Facial Plastic Surgery
9. Rigaku Introduces New Instruments at Pittcon 2013
10. GIN Introduces Advanced Robotics and Dispensing Technology at BVS La Jolla Biotech Day
11. FMC BioPolymer Introduces Its New Portfolio of Nature-Based Nutritional Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... ... the Fluidnatek® Electrospinning and Electrospraying line of nanofiber ... from table-top equipment for the lab to fully automated pilot plants and ...
(Date:8/16/2017)... Dilworth, MN (PRWEB) , ... August 16, 2017 ... ... of our third U.S. Food and Drug Administration (FDA) inspection at our Dilworth, ... 2017. No 483 was issued. This inspection was conducted as part of a ...
(Date:8/15/2017)... ... , ... Kapstone Medical is proud to announce that it has ... and inventors develop and safeguard their latest innovations. The company has grown from ... of clients in the United States and around the world. , Company Founder ...
(Date:8/15/2017)... Wisconsin (PRWEB) , ... August 15, 2017 , ... ... a new family of 6” modular downlights designed to stay tightly sealed and ... including areas where damp and wet location listings just aren't enough, such as: ...
Breaking Biology Technology:
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
Breaking Biology News(10 mins):